STEMart, a major source of comprehensive medical device CRO services dedicated to medical device and diagnostic clinical development has introduced sterility and microbiology testing for nonpyrogenic medical devices.
Neogen Corporation has introduced the Soleris NG microbial testing system, which automates the detection of microorganisms within a fraction of the time it would take to do traditional testing.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5065
Published Date: Jun 24, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing prevalence of infectious diseases, the rising demand for rapid and cost-effective tests are the major factors driving the market growth.
The market size of microbiology testing is anticipated to attain a CAGR of ~7% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Neogen Corporation., STEMart, Masimo, Koninklijke Philips N.V., GE Healthcare, and others.
The pharmaceutical segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The microbiology testing market is estimated to be USD 4 Billion by 2022 and forecasted to be USD 10 Billion by 2035.
This is propelled by the growing demand for rapid and automated testing methods, the increasing prevalence of infectious diseases, and the growing awareness about food safety and quality standards.
The unavailability of skilled personnel, issues with test accuracy and high cost of testing are some of the growth hampering factors affecting microbiology testing market.